Your browser doesn't support javascript.
loading
Iptacopan and danicopan for paroxysmal nocturnal hemoglobinuria.
Fahim, Shahariar Mohammed; Makam, Anil N; Suh, Kangho; Carlson, Josh J; Richardson, Marina; Herce-Hagiwara, Belen; Dickerson, Ronald; Pearson, Steven D; Agboola, Foluso.
Affiliation
  • Fahim SM; Institute for Clinical and Economic Review, Boston, MA.
  • Makam AN; Department of Medicine, University of California San Francisco.
  • Suh K; University of California San Francisco Philip R. Lee Institute for Health Policy Studies.
  • Carlson JJ; Department of Pharmacy & Therapeutics, School of Pharmacy, University of Pittsburgh, PA.
  • Richardson M; Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle.
  • Herce-Hagiwara B; Institute for Clinical and Economic Review, Boston, MA.
  • Dickerson R; Institute for Clinical and Economic Review, Boston, MA.
  • Pearson SD; Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, School of Pharmacy, University of Washington, Seattle.
  • Agboola F; Institute for Clinical and Economic Review, Boston, MA.
J Manag Care Spec Pharm ; 30(6): 618-623, 2024 Jun.
Article in En | MEDLINE | ID: mdl-38824627

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hemoglobinuria, Paroxysmal Limits: Humans Language: En Journal: J Manag Care Spec Pharm Year: 2024 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hemoglobinuria, Paroxysmal Limits: Humans Language: En Journal: J Manag Care Spec Pharm Year: 2024 Type: Article